356 related articles for article (PubMed ID: 7901248)
1. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
Shapiro J; Tan J; Ho V; Abbott F; Tron V
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):729-35. PubMed ID: 7901248
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
Shapiro J; Tan J; Ho V; Tron V
J Invest Dermatol; 1995 May; 104(5 Suppl):36S. PubMed ID: 7738390
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
Durdu M; Özcan D; Baba M; Seçkin D
J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
[TBL] [Abstract][Full Text] [Related]
4. Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration.
Khoury EL; Price VH; Abdel-Salam MM; Stern M; Greenspan JS
J Invest Dermatol; 1992 Jul; 99(1):40-7. PubMed ID: 1607678
[TBL] [Abstract][Full Text] [Related]
5. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
Aghaei S
BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
[TBL] [Abstract][Full Text] [Related]
6. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy.
Price VH
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):737-44. PubMed ID: 3549810
[TBL] [Abstract][Full Text] [Related]
7. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
Olsen EA; Carson SC; Turney EA
Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
[TBL] [Abstract][Full Text] [Related]
8. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata.
Fiedler-Weiss VC
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):745-8. PubMed ID: 3549811
[TBL] [Abstract][Full Text] [Related]
9. 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.
Fransway AF; Muller SA
Cutis; 1988 Jun; 41(6):431-5. PubMed ID: 3292159
[TBL] [Abstract][Full Text] [Related]
10. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
[TBL] [Abstract][Full Text] [Related]
12. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
[TBL] [Abstract][Full Text] [Related]
13. Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica.
Clissold SP; Heel RC
Drugs; 1987 Feb; 33(2):107-22. PubMed ID: 3552591
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
[TBL] [Abstract][Full Text] [Related]
15. Topical minoxidil dose-response effect in alopecia areata.
Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
[TBL] [Abstract][Full Text] [Related]
16. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata.
Price VH
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):730-6. PubMed ID: 3549809
[TBL] [Abstract][Full Text] [Related]
18. Topical minoxidil for hair regrowth.
Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
Ibrahim SA; Esawy AM; Abdelshafy AS
Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
